2008 Nobel Prize in Physiology or Medicine: Harald zur Hausen, Françoise Barré-Sinoussi, and Luc Montagnier – Cervical Cancer and AIDS

What You Will Learn from This Article

The 2008 Nobel Prize in Physiology or Medicine was awarded to three individuals for their discoveries related to two viruses that shook humanity in the late 20th century. Half of the prize went to Harald zur Hausen of the German Cancer Research Center (DKFZ) in Heidelberg – for demonstrating that the human papillomavirus (HPV) causes cervical cancer. The other half was shared by Françoise Barré-Sinoussi and Luc Montagnier of the Pasteur Institute in France – for the first isolation of the virus that causes AIDS, HIV. These two discoveries are the foundation for today's cervical cancer vaccines, such as Gardasil, and antiretroviral therapy (ART) that enables chronic management of HIV infection. They have also created two new axes of understanding: infection and cancer, and infection and immunodeficiency.

Beyond Common Knowledge: Infection Causes Cancer, Infection Destroys Immunity

The two widely accepted notions of the 20th century – “cancer is a disease of genetic mutations” and “the immune system is a system that fights off invaders” – were challenged by the three Nobel laureates in 2008.

The first exception: certain viruses can remain in a chronic infection state and disable the host cell's crucial tumor suppressor system, leading to cancer. This is how HPV causes cervical cancer. The E6 and E7 proteins of HPV bind to and inactivate human cell's tumor suppressor genes p53 and Rb, respectively. p53 is responsible for deciding the fate of damaged cells (apoptosis), and Rb controls the G1/S checkpoint of the cell cycle. When these two mechanisms are disabled, the cells become immortalized and continue to divide uncontrollably, leading to cancer over decades. In a CS framework, this is analogous to malware that corrupts constant references via the host, thereby bypassing assertions.

The second exception: certain viruses can target the immune system's command center, causing the body's defense system to collapse from within. This is how HIV infects CD4 T cells. CD4 T cells are the command cells of the acquired immune system; when these cells are killed, the entire immune response loses its leadership. A few years after infection, when the number of CD4 T cells drops below a certain threshold, AIDS (Acquired Immunodeficiency Syndrome) develops, and opportunistic infections and tumors, which would normally not cause problems, become rampant. This is similar to a system where a malicious process with administrator privileges executes instead of normal user traffic.

The Zeitgeist: Lehman, Obama, Mad Cow Disease, and Sungnyemun Gate

The fall of 2008 was a time of turmoil in the global financial system. The bankruptcy of Lehman Brothers on September 15th triggered the global financial crisis, leading to the worst recession since the Great Depression. It was the bursting of the subprime bubble, followed by massive government bailouts and quantitative easing. Two months later, on November 4th, Barack Obama was elected as the first African-American president of the United States. "Yes we can" became the slogan that represented the era of crisis and hope.

That summer, the Beijing Olympics were held from August 8th to 24th. It was a showcase of China's national power, and the scale and precision of the opening ceremony left a lasting impression. It marked a new stage in the international presence of Asian countries since the late 20th century.

In Korea, it was a turbulent year. On February 10th, Sungnyemun Gate, a national treasure, was destroyed in a fire. This revealed the vulnerability of the cultural heritage protection system, and a five-year restoration project followed. On February 25th, Lee Myung-bak took office as president, ushering in a pragmatic government, but soon after, from May to August, the controversy over U.S. beef and mad cow disease led to daily candlelight vigils in Gwanghwamun Square, with tens of thousands of people protesting. This was the first large-scale protest in which Internet communities and social media played a crucial role in mobilizing the public, and it greatly shook the government's governance. In December, the Jo Du-sun case occurred, and child sexual abuse and judicial justice became social issues, and in April, Lee Kun-hee resigned from his position as chairman of Samsung due to the special prosecutor's investigation.

In the scientific community, the Nobel Prize at this time had a special political dimension. There was a 15-year international patent dispute between the French Pasteur team and the Robert Gallo team at the U.S. National Institutes of Health over the priority of the discovery of HIV. The Nobel Committee's recognition of the French team effectively ended this dispute, and Gallo was excluded from the prize, which caused controversy. It was a moment when the Nobel Committee made a decision on the weighty issue of priority in the history of science.

Personal Narratives: Three Laboratories, Two Continents, Two Viruses

Harald zur Hausen (1936–2023) was born in Gelsenkirchen, Germany. He studied at the universities of Hamburg, Bonn, and Düsseldorf, and then at the universities of Freiburg and Erlangen, and in 1983, he became the director of the German Cancer Research Center (DKFZ) in Heidelberg. His hypothesis was clear from the beginning: "Cervical cancer is an infectious disease. And the cause is the human papillomavirus (HPV)."

In the 1970s, this hypothesis was largely ignored by the scientific community. At the time, the herpes virus (HSV-2) was considered the main suspect in cervical cancer. However, zur Hausen trusted his own observations – that HPV causes warts (common flat condylomas), and that warts and cervical lesions have similar histological characteristics. His laboratory developed a method to clone HPV genomes directly from cervical cancer tissue, and from 1983 to 1984, he reported that HPV 16 and 18 were detected in a significant proportion of cervical cancer tissues. It took another decade of epidemiological research to prove the causal relationship, and this relationship was confirmed in the early 21st century with the advent of large-scale vaccination programs. In his Nobel lecture, zur Hausen calmly recounted how much resistance his hypothesis had faced early on, and he expressed great pride in the fact that the Merck Gardasil vaccine was built upon his discovery.

Luc Montagnier (1932–2022) was born in Chabris, France. He studied at the universities of Poitiers and Paris and headed the viral department at the Pasteur Institute. Françoise Barré-Sinoussi (1947–) was born in Paris. She received her Ph.D. from the University of Paris and joined Montagnier's laboratory at the Pasteur Institute. The collaboration between the two began in 1982, shortly after mysterious immune deficiency diseases began to be discovered in young male patients in New York and San Francisco. Initially called GRID (Gay-Related Immune Deficiency), it was soon discovered that it was not related to gender or sexual orientation and was renamed AIDS.

In early 1983, the Pasteur team cultured lymph node tissue taken from a patient at the Salpêtrière Hospital in Paris. They discovered reverse transcriptase activity in this culture – an activity characteristic of retroviruses. The new retrovirus isolated from the tissue was initially named LAV (Lymphadenopathy-Associated Virus). Later, it was confirmed that this virus was the causative agent of AIDS, and it was renamed HIV (Human Immunodeficiency Virus).

At the same time, the laboratory of Robert Gallo at the U.S. National Institutes of Health isolated a similar virus and named it HTLV-III. The Pasteur team shared their LAV sample with Gallo, and it was discovered that the HTLV-III published by the Gallo team was very similar to the Pasteur LAV, leading to a 15-year dispute over priority. After several international consultations, the priority of the French team was finally recognized, and the Nobel Committee awarded the prize to the two members of the Pasteur team, effectively ending the long-running dispute.

Since the discoveries of the three, various anti-HIV drugs have been developed, starting with the reverse transcriptase inhibitor AZT (1987), followed by protease inhibitors and integrase inhibitors, and in 1996, HAART (Highly Active Antiretroviral Therapy) was established, changing the nature of AIDS from a death sentence to a chronic manageable disease. Today, HIV-infected individuals, if diagnosed early and treated continuously, can have a life expectancy similar to that of uninfected individuals.

Key Achievements: Two Viruses in the CS Framework

The HPV cervical cancer pathway can be described as follows:

• Entry: HPV enters the squamous epithelium of the cervix through sexual contact. In most cases, the infection is cleared by the immune system within a few years.
• Persistent Infection: In a small number of cases, the infection persists and becomes chronic. In some cases, the viral genome integrates into the host cell genome, and this integration is a risk factor.
• Assertion Bypass: The E6 protein of HPV binds to and ubiquitinates p53, leading to its degradation. The E7 protein binds to Rb, leading to its inactivation. Both of these tumor suppressor proteins are inactivated.
• Gradual Progression: These cells accumulate DNA damage and progress to cervical intraepithelial neoplasia (CIN) and eventually to invasive cervical cancer over years to decades.

The HIV CD4 T cell infection pathway is as follows:

• Entry: The HIV envelope protein gp120 binds to the CD4 receptor and a co-receptor (CCR5 or CXCR4). CD4 is a surface receptor of helper T cells.
• Reverse Transcription: The viral RNA enters the host cell and is copied into DNA by its own reverse transcriptase.
• Integration: The integrase inserts this DNA into the host genome, creating a provirus. This integration is irreversible, and the infected T cell carries the viral genome for life.
• Reactivation and Destruction: When the T cell is activated, the integrated provirus is expressed, producing a large number of new viral particles, and eventually the cell is destroyed. This process is repeated over years, gradually depleting CD4 T cells.
• Immune Collapse: When the number of CD4 T cells drops below 200/μL, the command center of the acquired immune system collapses, and pathogens and tumors that would normally be eliminated become rampant.

The CS side parallels of the two architectures are remarkably complementary. HPV is like assertion bypass malware that inactivates specific assertions so that the host program continues to run in an incorrect state. HIV is like a privilege escalation attack that takes over the administrator account and disables all of the system's defense decision-making capabilities. In the late 20th century, humanity gained a new understanding of the relationship between infection and pathology in two different ways.

Why it Matters: Vaccines, Chronic Management, and the Weight of Social History

The Impact of the HPV Vaccine is one of the greatest achievements in preventive medicine of the 21st century. With the approval of Merck's Gardasil in 2006 and GlaxoSmithKline's Cervarix in 2007, national vaccination programs aimed at achieving pre-emptive immunity against specific HPV types (such as high-risk types 16 and 18) before the onset of sexual activity have spread around the world. In South Korea, free vaccinations for 12-year-old girls were introduced in 2016 and later expanded to include boys. It takes more than 20 years for the effects of this vaccination to be confirmed by actual data, but even early observations show a significant reduction in cervical lesions. We are now living in a time when, after a long time, cervical cancer itself will be redefined as a preventable disease.

The Impact of HIV Treatment is also one of the greatest turning points in medicine in the late 20th century. In the early 1980s, a diagnosis of this disease was a death sentence, but with early diagnosis and antiretroviral therapy, it has transformed into a chronic disease that can be managed. U=U (Undetectable = Untransmittable) — the principle that if treated and the viral load in the blood is below the detection limit, it will not be transmitted through sexual contact — became an international official principle after 2016, and this has fundamentally reshaped the relationship between infection and social stigma. PrEP (Pre-Exposure Prophylaxis) — a method in which people at high risk of infection take anti-HIV drugs preventively — has also been established and has contributed greatly to reducing new infections.

We must also mention the weight of social history. HIV/AIDS was a disease that left an indelible scar on the LGBTQ+ community in the late 20th century, and many of the early infected people lived in an era when they died within a few years of diagnosis. Patient activist organizations such as ACT UP significantly changed the US FDA's new drug approval process and became the root of today's patient-centered clinical research culture. This story, in which scientific discoveries and social movements pushed each other forward, strongly demonstrates that medical progress takes place within a social context.

The evolutionary roots of HIV are also an interesting story. Genomic analysis shows that HIV originated from SIV (simian immunodeficiency virus) in chimpanzees in Central Africa, which spread across species and is estimated to have jumped to humans in the early 20th century. The social conditions that combined globalization, urbanization, and the blood transfusion industry in the late 20th century expanded the regional infection into a global pandemic. The perspective that a pandemic is not just a problem of pathogens, but also a problem of social structures became the standard view in the infectious disease community after this story, and this insight continued in the understanding of COVID-19 in 2020.

Two viruses, two laboratory traditions, one Nobel Prize. The eighth Nobel Prize in Physiology or Medicine of the new century was awarded for the two most significant infectious diseases of the late 20th century, and it has created two streams of vaccines and chronic management.

→ Previous: 2007 Nobel Prize in Physiology or Medicine → Next: 2009 Nobel Prize in Physiology or Medicine